Baird Medical director reports 20,000 BDMD shares

Baird Medical Investment Holdings Ltd director Gabrielle Bilciu-Wolfson has filed an initial Form 3 disclosing her stake in the company.

Accepted by SEC EDGAR 04/17/2026 - 03:31 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Baird Medical Investment Holdings Ltd director Gabrielle Bilciu-Wolfson has filed an initial Form 3 disclosing her stake in the company. She reports beneficial ownership of 20,000 shares of Baird Medical common stock, held directly, with no specific buy or sell transaction indicated in this filing.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Bilciu-Wolfson Gabrielle

Role Director

Type	Security	Shares	Price	Value
Holding	Baird Medical Investment Holdings LTD (BDMD) Common Stock	--	--	--

Holdings: Baird Medical Investment Holdings LTD (BDMD) Common Stock — 20,000 shares (Direct)

Key Figures

Shares owned: 20,000 shares Holding entries: 1 entry

2 metrics

Shares owned 20,000 shares Common stock beneficially owned following reported position

Holding entries 1 entry Initial Form 3 beneficial ownership record

Key Terms

Form 3, beneficial ownership, common stock, direct ownership

4 terms

Form 3 regulatory

"Director files Form 3 as an initial statement of beneficial ownership."

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"The filing reports beneficial ownership of 20,000 shares of common stock."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

common stock financial

"The security is described as Baird Medical common stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

direct ownership financial

"Ownership code D indicates direct ownership of the shares."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 for BDMD show about Gabrielle Bilciu-Wolfson?

The Form 3 shows that director Gabrielle Bilciu-Wolfson beneficially owns 20,000 shares of Baird Medical common stock. This is an initial ownership report, not a record of a new purchase or sale of shares.

How many BDMD shares does Gabrielle Bilciu-Wolfson report owning?

She reports owning 20,000 shares of Baird Medical common stock. These shares are listed as held directly, meaning they are not reported through an intermediary entity such as a trust or partnership in this filing.

Is Gabrielle Bilciu-Wolfson’s BDMD ownership direct or indirect?

Her 20,000-share position in Baird Medical common stock is reported as direct ownership. The ownership code is shown as “D,” indicating the shares are held in her own name rather than through another entity.

Does this BDMD Form 3 indicate any recent insider buying or selling?

No, the Form 3 functions as an initial statement of beneficial ownership and does not show a specific buy or sell transaction. It simply records that 20,000 common shares are owned following the reported position.

What is the role of Gabrielle Bilciu-Wolfson at Baird Medical (BDMD)?

She is identified as a director of Baird Medical Investment Holdings Ltd. As a director, she is required to report her beneficial ownership of company securities, which is what this Form 3 filing provides to the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Bilciu-Wolfson Gabrielle

(Last) (First) (Middle)

71 DIMMIG ROAD

(Street)

UPPER SADDLE RIVER NEW JERSEY 07458

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Baird Medical Investment Holdings Ltd [ BDMD ]

3a. Foreign Trading Symbol
[BDMD]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Baird Medical Investment Holdings LTD (BDMD) Common Stock	20,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Gabrielle Wolfson	04/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)